1
|
Kim SY, Lee JO, Lee S, Heo J, Cho KH, Bahuguna A, Yoo KH, Kim BJ. Ozonated Sunflower Oil (OSO) alleviates inflammatory responses in oxazolone-induced atopic dermatitis (AD)-like mice and LPS- treated RAW 264.7 cells. J Microbiol Biotechnol 2024; 34:1-10. [PMID: 38247218 DOI: 10.4014/jmb.2310.10037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Revised: 12/21/2023] [Accepted: 01/03/2024] [Indexed: 01/23/2024]
Abstract
Ozone, a highly reactive oxidant molecule, is widely used as a complementary therapy for various skin diseases, including wound healing, pressure ulcers, diabetic foot, and infections. However, there is limited research on the effectiveness of ozone for atopic dermatitis (AD). Ozonated sunflower oil (OSO) is an active ingredient obtained from partially ozonated sunflower oil (SO). OSO markedly reduced the LPS-induced increase in IL-1β and nitric oxide (NO) levels in RAW 264.7 mouse macrophage cells. Oxazolone (OXZ) was applied to hairless mice to induce AD-like skin symptoms and immune response. OSO significantly alleviated the OXZ-induced increases in the number of infiltrating mast cells, epidermal thickness, AD symptoms, thymic stromal lymphopoietin (TSLP), and filaggrin, as well as the serum levels of NO, IgE, IL-1β, and TNF-α. Furthermore, OSO inhibited the IL-4/STAT3/MAPK pathway and the expression of NF-κB. Our results suggest that OSO treatment could relieve AD-mediated skin damage through its anti-inflammatory and antioxidant activities. Therefore, it can be used as a therapeutic agent against AD-related skin diseases.
Collapse
Affiliation(s)
- Su-Young Kim
- Department of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea
- Department of Medicine, Graduate School, Chung-Ang University, Seoul 06973, Republic of Korea
| | - Jung Ok Lee
- Department of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea
| | - Sue Lee
- Department of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea
- Department of Medicine, Graduate School, Chung-Ang University, Seoul 06973, Republic of Korea
| | - Jihye Heo
- Department of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea
- Department of Medicine, Graduate School, Chung-Ang University, Seoul 06973, Republic of Korea
| | - Kyung-Hyun Cho
- Raydel Research Institute, Medical Innovation Complex, Daegu 41061, Republic of Korea
| | - Ashutosh Bahuguna
- Raydel Research Institute, Medical Innovation Complex, Daegu 41061, Republic of Korea
| | - Kwang-Ho Yoo
- Department of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea
| | - Beom Joon Kim
- Department of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea
- Department of Medicine, Graduate School, Chung-Ang University, Seoul 06973, Republic of Korea
| |
Collapse
|
2
|
Lee J, Heo J, Jeon KO. Analysis of the degree of alcohol dependence and codependence of family members in patients who underwent liver transplantation for alcoholic liver disease. Korean Journal of Transplantation 2022. [DOI: 10.4285/atw2022.f-5124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Jieun Lee
- Transplant Support Team, Severance Hospital Organ Transplant Center, Seoul, Korea
| | - Jihye Heo
- Transplant Support Team, Severance Hospital Organ Transplant Center, Seoul, Korea
| | - Kyung-Ok Jeon
- Transplant Support Team, Severance Hospital Organ Transplant Center, Seoul, Korea
| |
Collapse
|
3
|
Affiliation(s)
- Jihye Heo
- Department of Biomedical Laboratory Science, Donggang University, Gwangju, Korea
| |
Collapse
|
4
|
Lee JH, Kim S, Heo J, Park DH, Chang E. Differences in the muscle activities of the quadriceps femoris and hamstrings while performing various squat exercises. BMC Sports Sci Med Rehabil 2022; 14:12. [PMID: 35063016 PMCID: PMC8783452 DOI: 10.1186/s13102-022-00404-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Accepted: 01/05/2022] [Indexed: 11/10/2022]
Abstract
Background Knee injuries in the lower limbs frequently occur, and lower limb muscles need to be strengthened to reduce injuries. Activating muscles can help strengthen muscles.. This study aimed to determine the squat exercises [general squat (GS), wall squat (WS), and Spanish squat (SS)] that effectively increased muscle activity using electromyography (EMG). Methods In this cross-sectional study, 22 participants performed three different squat exercises with EMG attached to the rectus femoris (RF), vastus lateralis (VL), vastus medialis, biceps femoris, semitendinosus, and semimembranosus. The Kruskal–Wallis H test was used to compare thigh muscle activities among the various squat exercises. Results During SS, RF showed greater muscle activation compared to WS and GS (RF: χ2 = 21.523, p = 0.000, η2 = 0.333). VL also showed greater muscle activation during SS compared to WS (VL: χ2 = 7.101, p = 0.029, η2 = 0.109). Conclusions The results from this study indicate that SS shows more activation in the RF and VL muscles compared to GS and WS. These findings suggest that SS can provide more muscle activation for the RF and VL muscles and will greatly help those who lack muscle activation in these muscles.
Collapse
Affiliation(s)
- Joo-Hyun Lee
- College of Arts and Sports, Department of Kinesiology, Inha University, 5W555B, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea
| | - Soojin Kim
- College of Arts and Sports, Department of Kinesiology, Inha University, 5W555B, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.,Institute of Sports and Arts Convergence (ISAC), Inha University, W-440, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea
| | - Jihye Heo
- College of Arts and Sports, Department of Kinesiology, Inha University, 5W555B, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea
| | - Dong-Ho Park
- College of Arts and Sports, Department of Kinesiology, Inha University, 5W555B, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.,Institute of Sports and Arts Convergence (ISAC), Inha University, W-440, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea
| | - Eunwook Chang
- College of Arts and Sports, Department of Kinesiology, Inha University, 5W555B, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea. .,Institute of Sports and Arts Convergence (ISAC), Inha University, W-440, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.
| |
Collapse
|
5
|
Bae Y, Heo J, Chung Y, Shin SY, Lee SW. Effect of total cholesterol level variabilities on cerebrovascular disease. Eur Rev Med Pharmacol Sci 2022; 26:544-557. [PMID: 35113431 DOI: 10.26355/eurrev_202201_27882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE Hyperlipidemia is a risk factor of cerebrovascular disease (CVD). However, the relationship between CVD and cholesterol variability is less clear. This study assesses the relationship between cholesterol change and CVD risk. PATIENTS AND METHODS We reviewed 480,830 people from 20 to 99 years with 2 health check-ups from 2002 to 2015 from the Korean National Health Insurance (KNHI) database. People's baseline and follow-up cholesterol levels were classified into low (<180 mg/dL), moderate (≥180 mg/dL and <240 mg/dL), and high (≥240 mg/dL). Participants were divided into 9 groups (low-to-low, low-to-moderate, low-to-high, moderate-to-low, moderate-to-moderate, moderate-to-high, high-to-low, high-to-moderate, high-to-high). RESULTS Low to high cholesterol level is associated with hemorrhagic stroke (aHR1 = 1.59; 95% CI 1.12-2.28 and aHR2 = 1.56; 95% CI 1.07-2.25). Low to moderate/high cholesterol level is associated with ischemic stroke and occlusion/stenosis (for low to moderate, aHR1 = 1.11; 95% CI 1.04-1.17 and aHR2 = 1.14; 95% CI 1.07-1.21 for ischemic stroke and aHR1 = 1.18; 95% CI 1.07-1.29 and aHR2 = 1.20; 95% CI 1.08-1.32 for occlusion/stenosis, for low to high, aHR1 = 1.42; 95% CI 1.20-1.67 and aHR2 = 1.28; 95% CI 1.08-1.52 for ischemic stroke and aHR1 = 1.86; 95% CI 1.46-2.36 and aHR2= 1.74; 95% CI 1.36-2.23 for occlusion/stenosis). Moderate to high cholesterol level is associated with ischemic stroke and occlusion/stenosis (for ischemic stroke, aHR1 = 1.12; 95% CI 1.05-1.20 and aHR2 = 1.10; 95% CI 1.03-1.17, for occlusion/stenosis, aHR1 = 1.21; 95% CI 1.10-1.33 and aHR2 = 1.19; 95% CI 1.08-1.32). Moderate to low cholesterol level is associated with ischemic and hemorrhagic stroke and occlusion/stenosis (for ischemic, aHR1 = 1.15; 95% CI 1.09-1.21, for hemorrhagic, aHR1 = 1.14; 95% CI 1.01-1.28, for occlusion/stenosis, aHR1 = 1.14; 95% CI 1.05-1.23). High to low cholesterol level is associated with ischemic stroke and occlusion/stenosis (for ischemic stroke, aHR1 = 1.51; 95% CI 1.33-1.71 and aHR2 = 1.20; 95% CI 1.05-1.36, for occlusion/stenosis, aHR1 = 1.50; 95% CI 1.24-1.81). CONCLUSIONS Our study shows that cholesterol changes, especially larger changes, lead to an increase in CVD, which demonstrates that cholesterol variability may increase CVD.
Collapse
Affiliation(s)
- Y Bae
- Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
| | | | | | | | | |
Collapse
|
6
|
Heo J, Kim Y, Lee J, Lee S, Shin S, Lee Y, Kim S, Choi J, Kim S. 756P Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
7
|
Lanfredini M, Bestion D, D'Auria F, Aksan N, Fillion P, Gaillard P, Heo J, Karppinen I, Kim K, Kurki J, Liu L, Shen A, Vacher JL, Wang D. Critical flow prediction by system codes – Recent analyses made within the FONESYS network. Nuclear Engineering and Design 2020. [DOI: 10.1016/j.nucengdes.2020.110731] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
8
|
Hossain M, Park DS, Rahman MS, Ki SJ, Lee YR, Imran KM, Yoon D, Heo J, Lee TJ, Kim YS. Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508 culture-supernatant ameliorate obesity by inducing thermogenesis in obese-mice. Benef Microbes 2020; 11:361-373. [PMID: 32755263 DOI: 10.3920/bm2019.0179] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Excessive body fat and the related dysmetabolic diseases affect both developed and developing countries. The aim of this study was to investigate the beneficial role of a bacterial culture supernatant (hereafter: BS) of Lactobacillus and Bifidobacterium and their potential mechanisms of action on white-fat browning and lipolysis. For selection of four candidates among 55 Lactic acid producing bacteria (LAB) from human infant faeces, we evaluated by Oil Red O staining and Ucp1 mRNA quantitation in 3T3-L1 preadipocytes. The expression of browning and lipolysis markers was examined along with in vitro assays. The possible mechanism was revealed by molecular and biological experiments including inhibitor and small interfering RNA (siRNA) assays. In a mouse model, physiological, histological, and biochemical parameters and expression of some thermogenesis-related genes were compared among six experimental groups fed a high-fat diet and one normal-diet control group. The results allow us to speculate that BS treatment promotes browning and lipolysis both in vitro and in vivo. Moreover, the BS may activate thermogenic programs via a mechanism involving PKA-CREB signaling in 3T3-L1 cells. According to our data, we can propose that two LAB strains, Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508, may be good candidates for a dietary supplement against obesity and metabolic diseases; however, further research is required for the development as dietary supplements or drugs.
Collapse
Affiliation(s)
- M Hossain
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - D-S Park
- Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si, Jeollabuk-do 580-185, Republic of Korea
| | - M S Rahman
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - S-J Ki
- Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si, Jeollabuk-do 580-185, Republic of Korea
| | - Y R Lee
- Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si, Jeollabuk-do 580-185, Republic of Korea
| | - K M Imran
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - D Yoon
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - J Heo
- International Agricultural Development and Cooperation Center, Chonbuk National University, Jeonju 54896, Republic of Korea
| | - T-J Lee
- Department of Anatomy, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea
| | - Y-S Kim
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| |
Collapse
|
9
|
Choi S, Park J, Shin H, Heo J, Kim W. How Do Caregivers of Children with Congenital Heart Disease Navigate the Health Care System in Ethiopia? Health Serv Res 2020; 55:65-65. [PMCID: PMC7440601 DOI: 10.1111/1475-6773.13418] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/27/2023] Open
Abstract
Research Objective Global surgery is becoming an increasingly important global health agenda. Cardiovascular disease is the major cause of mortality around the world, and congenital heart disease is the leading cause of morbidity in children. This study aimed to investigate and illustrate the caregivers’ experiences of accessing the health care system and undergoing pediatric cardiac surgery for children with congenital heart disease (CHD). Study Design A qualitative study was conducted. Interviews were conducted in December 2019 in Amharic, then translated into English using trained local interpreters. Data were transcribed verbatim and analyzed according to the principles of interpretive thematic analysis, informed by the candidacy framework, using NVivo. The candidacy framework explores the access to health care utilization by seven elements: candidacy, navigation, the permeability of services, appearances at health services, adjudications, offers and resistance, and operating conditions and the local production of candidacy. Population Studied Interviews were conducted with 13 caregivers of 10 patients with congenital heart disease that received cardiac surgery during the week of the interview. Principal Findings The following three themes emerged from the interviews: (a) Recognition of CHD mostly took place at birth, but for those born at home, they found out much later (max 14 years); (b) CHD was misdiagnosed multiple times prior to seeking care at a large hospital; and (c) patients were waiting for the surgery for more than a year, (d) being scheduled for surgery induced both anxiety and hopefulness. In the discussion, caregivers had financial difficulties and struggled in a fragmented delivery system and experienced poor service quality such as the inaccuracy of diagnosis while navigating the Ethiopian health care system. Conclusions Major care‐seeking delays were related to the inefficient and complex health care system, largely due to lack of early CHD recognition and financial hardships. Financial protection is low despite the availability of fee waivers for medications. Low education attainment and distance to hospitals are contributing to this challenge. Implications for Policy or Practice Overall, Ethiopia needs to prioritize policies that protect the financial status of low‐income households that need health care services. Along with increasing health care workforce capacity for pediatric cardiac surgeries in Ethiopia, there is a need to strengthen the district‐level screening capacity to facilitate earlier diagnosis at easily accessible health care settings. Primary Funding Source Search Results Web results Korea International Cooperation Agency.
Collapse
Affiliation(s)
- S. Choi
- Boston University School of Public HealthBostonMAUnited States
| | - J. Park
- Johns Hopkins Bloomberg School of Public HealthBaltimoreMDUnited States
| | - H. Shin
- JW LEE Center for Global MedicineSeoulKorea
| | - J. Heo
- Government institution (South Korea)SeoulKorea
| | - W.‐H. Kim
- JW LEE Center for Global MedicineSeoul National UniversitySeoulKorea
| |
Collapse
|
10
|
Johnstone EV, Bailey DJ, Lawson S, Stennett MC, Corkhill CL, Kim M, Heo J, Matsumura D, Hyatt NC. Synthesis and characterization of iodovanadinite using PdI 2, an iodine source for the immobilisation of radioiodine. RSC Adv 2020; 10:25116-25124. [PMID: 35517431 PMCID: PMC9055183 DOI: 10.1039/d0ra04114a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Accepted: 06/14/2020] [Indexed: 12/02/2022] Open
Abstract
The synthesis of a palladium-containing iodovanadinite derivative, hypothetically “PdPb9(VO4)6I2”, was attempted using PdI2 as a source of iodine in searching for a novel waste form for radioiodine. Stoichiometric amounts of Pb3(VO4)2 and PdI2 were batched and reacted at elevated temperatures in sealed vessels. Batched material was also subjected to high-energy ball-milling (HEBM) in order to reduce reaction time and the potential for iodine volatilization during subsequent reaction at 200–500 °C. The resulting products were characterized using X-ray diffraction, scanning electron microscopy, energy-dispersive X-ray analysis, IR spectroscopy, thermal analysis and Pd K XANES. Results showed that PdI2 can function as a sacrificial iodine source for the formation of iodovanadinite, prototypically Pb10(VO4)6I2, however, the incorporation of Pd into this phase was not definitively observed. The sacrificial reaction mechanism involved the decomposition of PdI2 to Pd metal and nascent I2, with the latter incorporated into the iodovanadinite Pb10(VO4)6I2 phase. In comparison to processing using standard solid state reaction techniques, the use of HEBM prior to high temperature reaction generates a more homogeneous end-product with better iodine retention for this system. Overall, the key novelty and importance of this work is in demonstrating a method for direct immobilisation of undissolved PdI2 from nuclear fuel reprocessing, in a composite wasteform in which I-129 is immobilised within a durable iodovandinite ceramic, encapsulating Pd metal. The synthesis and characterisation of a composite wasteform, comprising iodovanadinite Pb10(VO4)6I2 and Pd metal, is reported, for immobilisation of radioiodine PdI2; the formation of Pd incorporated iodovanadinite “PdPb9(VO4)6I2” was not observed.![]()
Collapse
Affiliation(s)
- E. V. Johnstone
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - D. J. Bailey
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - S. Lawson
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - M. C. Stennett
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - C. L. Corkhill
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - M. Kim
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
- Department of Materials Science and Engineering
| | - J. Heo
- Department of Materials Science and Engineering
- Pohang University of Science and Technology (POSTECH)
- Pohang
- South Korea
- Division of Advanced Nuclear Engineering
| | - D. Matsumura
- Materials Sciences Research Center
- Japan Atomic Energy Agency
- Sayo
- Japan
| | - N. C. Hyatt
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| |
Collapse
|
11
|
Bogere P, Choi Y, Heo J. Probiotics as alternatives to antibiotics in treating post-weaning diarrhoea in pigs: Review paper. S AFR J ANIM SCI 2019. [DOI: 10.4314/sajas.v49i3.1] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Moehler M, Heo J, Lee HC, Tak WY, Chao Y, Paik SW, Yim HJ, Byun KS, Baron A, Ungerechts G, Jonker D, Ruo L, Cho M, Kaubisch A, Wege H, Merle P, Ebert O, Habersetzer F, Blanc JF, Rosmorduc O, Lencioni R, Patt R, Leen AM, Foerster F, Homerin M, Stojkowitz N, Lusky M, Limacher JM, Hennequi M, Gaspar N, McFadden B, De Silva N, Shen D, Pelusio A, Kirn DH, Breitbach CJ, Burke JM. Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE). Oncoimmunology 2019; 8:1615817. [PMID: 31413923 PMCID: PMC6682346 DOI: 10.1080/2162402x.2019.1615817] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Revised: 04/15/2019] [Accepted: 04/19/2019] [Indexed: 02/07/2023] Open
Abstract
Pexastimogene devacirepvec (Pexa-Vec) is a vaccinia virus-based oncolytic immunotherapy designed to preferentially replicate in and destroy tumor cells while stimulating anti-tumor immunity by expressing GM-CSF. An earlier randomized Phase IIa trial in predominantly sorafenib-naïve hepatocellular carcinoma (HCC) demonstrated an overall survival (OS) benefit. This randomized, open-label Phase IIb trial investigated whether Pexa-Vec plus Best Supportive Care (BSC) improved OS over BSC alone in HCC patients who failed sorafenib therapy (TRAVERSE). 129 patients were randomly assigned 2:1 to Pexa-Vec plus BSC vs. BSC alone. Pexa-Vec was given as a single intravenous (IV) infusion followed by up to 5 IT injections. The primary endpoint was OS. Secondary endpoints included overall response rate (RR), time to progression (TTP) and safety. A high drop-out rate in the control arm (63%) confounded assessment of response-based endpoints. Median OS (ITT) for Pexa-Vec plus BSC vs. BSC alone was 4.2 and 4.4 months, respectively (HR, 1.19, 95% CI: 0.78–1.80; p = .428). There was no difference between the two treatment arms in RR or TTP. Pexa-Vec was generally well-tolerated. The most frequent Grade 3 included pyrexia (8%) and hypotension (8%). Induction of immune responses to vaccinia antigens and HCC associated antigens were observed. Despite a tolerable safety profile and induction of T cell responses, Pexa-Vec did not improve OS as second-line therapy after sorafenib failure. The true potential of oncolytic viruses may lie in the treatment of patients with earlier disease stages which should be addressed in future studies. ClinicalTrials.gov: NCT01387555
Collapse
Affiliation(s)
- M Moehler
- First Department of Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - J Heo
- College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - H C Lee
- Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Republic ofKorea
| | - W Y Tak
- School of Medicine, Kyungpook National University Medical Center, Daegu, Republic of Korea
| | - Y Chao
- Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
| | - S W Paik
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - H J Yim
- Department of Internal Medicine, Korea University Ansan Hospital, Ansan-si, Republic of Korea
| | - K S Byun
- Department of Internal Medicine, Korea UniversityCollege of Medicine, Seoul, Republic of Korea
| | - A Baron
- Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA
| | - G Ungerechts
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany
| | - D Jonker
- The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
| | - L Ruo
- Department of Surgery, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Canada
| | - M Cho
- Department of Internal Medicine, Pusan National University Yangsan Hospital, Busan, Republic of Korea
| | - A Kaubisch
- Department of Medicine, Montefiore Medical Center, New York, NY, USA
| | - H Wege
- Department of Medicine, Gastroenterology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - P Merle
- Hepatology Unit, Croix-Rousse Hospital, Lyon, France
| | - O Ebert
- Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar, Technical University, Munich, Germany
| | - F Habersetzer
- Pôle Hépato-Digestif, Hôpitaux Universitaires de Strasbourg, INSERM 1110, IHU de Strasbourg and Université de Strasbourg, Strasbourg, France
| | - J F Blanc
- Hepato-Gastroenterology and Digestive Oncology Department, CHU Bordeaux, Bordeaux, France
| | | | - R Lencioni
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
| | - R Patt
- Rad-MD, New York, NY, USA
| | - A M Leen
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - F Foerster
- First Department of Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - M Homerin
- Medical Affairs, Transgene S.A., Illkirch-Graffenstaden, France
| | - N Stojkowitz
- Clinical Operations, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France
| | - M Lusky
- Program Management, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France
| | - J M Limacher
- Medical Affairs, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France
| | - M Hennequi
- Biostatistics, Transgene S.A., 400 Bd Gonthier d'Andernach, Parc d'Innovation, 67405 Illkirch-Graffenstaden, France
| | - N Gaspar
- Clinical Assays, SillaJen Inc., San Francisco, CA, USA
| | - B McFadden
- Analytical Development and Quality Control, SillaJen Inc., San Francisco, CA, USA
| | - N De Silva
- Clinical, SillaJen Inc., San Francisco, CA, USA
| | - D Shen
- Clinical, SillaJen Inc., San Francisco, CA, USA
| | - A Pelusio
- Clinical, SillaJen Inc., San Francisco, CA, USA
| | - D H Kirn
- SillaJen Inc., San Francisco, CA, USA
| | | | - J M Burke
- Clinical, SillaJen Inc., San Francisco, CA, USA
| |
Collapse
|
13
|
Abstract
Salvage therapy for recurrent high grade gliomas (HGG) includes surgery, radiotherapy and chemotherapy, however, standard treatment does not exist. We evaluated the tolerability and efficacy of re-irradiation (re-RT) with hyperthermia (HT) for patients with recurrent HGG. From September 2010 to July 2015, 20 patients with recurrent HGG were treated with re-RT and HT. The radiotherapy dose of 30 Gray (Gy) was delivered with 2 Gy per fraction daily, and HT was performed twice weekly. Primary endpoints were treatment compliance and toxicity. Second endpoints were overall survival (OS) and progression free survival (PFS). The median interval between initial RT and re-RT was 11 months. During re-RT with HT, there were no significant acute morbidities over grade 3. Median overall survival (OS) from re-irradiation was 8.4 months and the 6 and 12 months survival rate were 67% and 30%, respectively. The median progression free survival (PFS) from re-irradiation was 4.1 month. Our findings suggested that concurrent re-RT with HT was a safe and well-tolerated. In addition, the combination re-RT and HT could be a valuable salvage treatment option for selected recurrent HGG patients with poor performance status.
Collapse
|
14
|
Heo J, Oh Y, Noh O, Chun M, Cho O. PO-0711 Second Primary Cancer in Salivary gland cancer in South Korea: A Nationwide Population-based Study. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31131-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
15
|
Cho O, Oh Y, Chun M, Noh O, Heo J. PV-0042 Radiation related lymphopenia as a predictor of locoregional recurrence in early breast cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30462-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
Wilkins L, Hawrylack A, Heo J, Gielata M, Kubicka E, Brautigan D. 04:03 PM Abstract No. 390 Pharmacokinetic verification of loco-regional delivery of caffeic acid using drug-eluting beads in a large animal model. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
17
|
Heo J, Oh Y, Noh O, Chun M, Kim C, Shin Y. PO-139 Second Primary Cancer in Salivary gland cancer: A Nationwide Population-based Study. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30305-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Lee M, Park H, Heo J, Choi H, Seo S. 181 Multi-tissue transcriptomic analysis of the effects of supplementation of L- or D-methionine in acute heat stress-exposed broiler chickens. J Anim Sci 2018. [DOI: 10.1093/jas/sky404.659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Lee
- Chungnam National University,Daejon, South Korea
| | - H Park
- Chungnam National University,Daejon, South Korea
| | - J Heo
- Chungnam National University,Daejon, South Korea
| | - H Choi
- CJ Cheiljedang,Seoul, South Korea
| | - S Seo
- Chungnam National University,Daejon, South Korea
| |
Collapse
|
19
|
Wickramasuriya S, Kim E, Macelline S, Shin T, Cho H, Heo J. PSXVI-35 Egg production performance and egg quality of laying hens fed a diet supplemented with deoxynivalenol mycotoxins contaminated corn distillers dried grains with soluble. J Anim Sci 2018. [DOI: 10.1093/jas/sky404.736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - E Kim
- Chungnam National University,Daejeon, South Korea
| | - S Macelline
- Chungnam National University,Daejeon, South Korea
| | - T Shin
- Chungnam National University,Daejeon, South Korea
| | - H Cho
- Chungnam National University,Daejeon, South Korea
| | - J Heo
- Chungnam National University,Daejeon, South Korea
| |
Collapse
|
20
|
Lee S, Choi E, Heo J, Kim S, Lee S, Jo S, Won Y. GROUP VOLUNTEERING AS SERIOUS LEISURE AND SUCCESSFUL AGING. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - E Choi
- Colorado State University
| | | | | | | | | | | |
Collapse
|
21
|
Heo J, Cheng AL, Raoul JL, Peck-Radosavljevic M, Kudo M, Nakajima K, Bayh I, Lin SM, Lee H. Practice patterns, radiologic tumor response, and deterioration of liver function after transarterial chemoembolization (TACE): Final analysis of OPTIMIS in Korea and other regions. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy432.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
22
|
Han SS, Heo J, Lee SJ. Risk of lung cancer following pulmonary tuberculosis: A nationwide population-based cohort study, South Korea. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Lee H, Jung J, Heo J. P1.15-14 Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
24
|
Lee O, Kim K, Kim J, Kim YD, Pak H, Hong G, Chim CY, Uhm J, Cho I, Joung B, Yu C, Lee H, Kang W, Heo J, Jang Y. P3830Favorable neurological outcomes of left atrial appendage occlusion versus non-vitamin K antagonist oral anticoagulants after stroke in atrial fibrillation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- O Lee
- Severance Hospital, Cardiology, Yongin, Korea Republic of
| | - K Kim
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - J Kim
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - Y D Kim
- Severance Hospital, Neurology, Seoul, Korea Republic of
| | - H Pak
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - G Hong
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - C Y Chim
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - J Uhm
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - I Cho
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - B Joung
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| | - C Yu
- Korea University Anam Hospital, Cardiology, Seoul, Korea Republic of
| | - H Lee
- Sejong General Hospital, Cardiology, Seoul, Korea Republic of
| | - W Kang
- Gil Hospital, Cardiology, Incheon, Korea Republic of
| | - J Heo
- Severance Hospital, Neurology, Seoul, Korea Republic of
| | - Y Jang
- Severance Hospital, Cardiology, Seoul, Korea Republic of
| |
Collapse
|
25
|
Heo J, Oh Y, Noh O, Chun M, Cho O. EP-1109: Psychiatric comorbidity among nasopharynx cancer survivors who received radiotherapy in South Korea. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31419-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
26
|
Cho O, Oh Y, Chun M, Noh O, Heo J. P1.15-015 Prognostic Implication of the FEV1/FVC Ratio in Limited-Stage Small Cell Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
Song H, Kim Y, Park J, Park M, Lyu S, Koh Y, Heo J, Lee D, Park K. Biocompatible nanoparticle PLGA is a noble safe delivery system for embryo development and next generations. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
28
|
Choi Y, Lyu S, Park H, Park M, Lee S, Cho M, Ko J, Koh Y, Heo J, Park H, Kim J, Lee W. Differences in endometrial microbial composition correlate with implantation failure after IVF embryo transfer. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.1087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
29
|
Choe S, Kim S, Jun Y, Lee W, Kang I, Koong M, Heo J, Sim C, Koh Y, Park D, Yoon T. Ambient air pollution is associated with success of in-vitro fertilization cycles: a retrospective study in Seoul, Korea. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.959] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
30
|
Yu E, Sim C, Park D, Koh Y, Heo J, Choe S, Kim J, Koong M, Kang I, Yoon T, Kim Y. Relationship between heavy metal concentration and number of spontaneous abortion experiences in Korean women: a retrospective study of the 6th Korean national health and nutrition examination survey. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Han E, Koh Y, Heo J, Kim M, Lee H, Park H, Kim J, Lee W. Efficacy of granulocyte colony stimulation factor(G-CSF) administration to improve IVF outcomes: a meta-analysis. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.1037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
32
|
Choe S, Kim Y, Kang I, Sim C, Heo J, Koh Y, Koong M, Yoon T, Park D, Lee Y, Kim J, Kim M. Risk factors for premature or early menopause: a comparative study between United States and South Korean women. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Affiliation(s)
- J. Ryu
- Texas A&M University, College Station, Texas,
| | - H. Yang
- Texas A&M University, College Station, Texas,
| | - A.C. Kim
- University of Florida, Gainesville, Florida
| | - K. Kim
- University of Miami, Miami, Florida,
| | - J. Heo
- Texas A&M University, College Station, Texas,
| |
Collapse
|
34
|
Affiliation(s)
- J. Heo
- Charles E. Schmidt College of Medicine at Florida Atlantic University, Boca Raton, Florida
| | - M. Tolea
- Charles E. Schmidt College of Medicine at Florida Atlantic University, Boca Raton, Florida
| | - J.E. Galvin
- Charles E. Schmidt College of Medicine at Florida Atlantic University, Boca Raton, Florida
| |
Collapse
|
35
|
Heo J, Oh Y, Noh O, Chun M, Park J, Cho S. EP-1268: Tumor response according to NK cell change during preoperative chemoradiotherapy in rectal cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31703-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
36
|
Lee HK, Heo J, Myung S, Shin IS, Kim TH. Homogeneous Electrochemical Assay for Real-time Monitoring of Exonuclease III Activity Based on a Graphene Monolayer. ELECTROANAL 2017. [DOI: 10.1002/elan.201700006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- Heon-Kyu Lee
- Department of Chemistry; Soonchunhyang University; Asan 31538 Republic of Korea
| | - Jihye Heo
- Department of Chemistry; Soonchunhyang University; Asan 31538 Republic of Korea
| | - Sung Myung
- Thin Film Materials Research Center; Korea Research Institute of Chemical Technology; Daejeon 34114 Republic of Korea
| | - Ik-Soo Shin
- Department of Chemistry; Soongsil University; Seoul 06978 Republic of Korea
| | - Tae Hyun Kim
- Department of Chemistry; Soonchunhyang University; Asan 31538 Republic of Korea
| |
Collapse
|
37
|
Abstract
Attempts to synthesize “AgM9(VO4)6I” (M = Ba, Pb), potential waste form materials for radioiodine, were unsuccessful, demonstrating that AgI incorporation into an iodine-deficient apatite phase is not feasible under the reported conditions.
Collapse
Affiliation(s)
- E. V. Johnstone
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - D. J. Bailey
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - M. C. Stennett
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| | - J. Heo
- Department of Materials Science and Engineering
- Pohang University of Science and Technology (POSTECH)
- Pohang
- South Korea
- Division of Advanced Nuclear Engineering
| | - N. C. Hyatt
- University of Sheffield
- Materials Science and Engineering Department
- Sheffield
- UK
| |
Collapse
|
38
|
Choi B, Yang J, Ryu C, Shin SJ, Kim Y, Heo J, Cho S, Choi NJ. 1566 Effect of dietary polyphenol, protected amino acid, and crude protein levels on in vitro rumen fermentation and crude protein digestibility. J Anim Sci 2016. [DOI: 10.2527/jam2016-1566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Yang J, Ryu C, Shin SJ, Choi B, Kim Y, Park M, Heo J, Cho S, Choi NJ. 1618 Effect of different microbial inoculants on fermentation characteristics of Miscanthus silage and their rumen fermentation and digestibility. J Anim Sci 2016. [DOI: 10.2527/jam2016-1618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Heo J, Hwang K, Moon Y, Kim J, Lee J, Tak T, Choi J. Sub-acute oral toxicity study of soybean [Glycine max (L.) Merr.] whole plant extract in rats. Toxicol Lett 2016. [DOI: 10.1016/j.toxlet.2016.06.1725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Ahn SH, Lim YS, Lee KS, Paik SW, Lee YJ, Jeong SH, Kim JH, Yoon SK, Yim HJ, Tak WY, Han SY, Yang JC, Mo H, Mathias A, Han L, Knox SJ, Brainard DM, Kim YJ, Byun KS, Kim YS, Heo J, Han KH. A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus. J Viral Hepat 2016; 23:358-65. [PMID: 26864153 DOI: 10.1111/jvh.12499] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Accepted: 11/05/2015] [Indexed: 01/04/2023]
Abstract
In Korea, patients with chronic hepatitis C virus (HCV) infection are typically treated with pegylated interferon-alpha plus ribavirin, but interferons are contraindicated in many patients and are often poorly tolerated, particularly by the elderly and those with advanced liver disease. No interferon-free treatment regimens are approved in Korea. Sofosbuvir is an oral nucleotide analog inhibitor of the HCV nonstructural 5B RNA polymerase. It is approved in the USA, European Union and Japan for treating a number of HCV genotypes, including genotype 2. Genotype 2 has a seroprevalence of 38-46% in Korea. This single-arm, phase 3b study (NCT02021643) examined the efficacy and safety of sofosbuvir plus ribavirin (12-week duration) in chronic genotype 2 HCV-infected treatment-naive and treatment-experienced Korean patients with and without cirrhosis. The proportion of patients with sustained virologic response 12 weeks after treatment discontinuation (SVR12) was 97% (125/129), with 96% (101/105) of treatment-naive and 100% (24/24) of treatment-experienced patients achieving SVR12. Two patients experienced virologic failure (n = 1, on-treatment failure; n = 1, relapse). No patient discontinued study treatment due to an adverse event (AE). The most common treatment-emergent AEs were headache (18%, 23/129) and pruritus (15%, 19/129). Few patients had grade 3 AEs (5%, 6/129) or grade 3 laboratory abnormalities (12%, 15/129). No grade 4 AE was reported. These data suggest that 12 weeks of treatment with the all-oral, interferon-free regimen of sofosbuvir plus ribavirin is effective and well tolerated in Korean patients with chronic genotype 2 HCV infection.
Collapse
Affiliation(s)
- S H Ahn
- Yonsei University College of Medicine, Seoul-Korea, South Korea
| | - Y S Lim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul-Korea, South Korea
| | - K S Lee
- Gangnam Severance Hospital, Yonsei University Health System, Seoul-Korea, South Korea
| | - S W Paik
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul-Korea, South Korea
| | - Y J Lee
- Pusan Paik Hospital, Inje University, Busan-Korea, South Korea
| | - S H Jeong
- Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Korea, South Korea
| | - J H Kim
- Gachon University Gil Hospital, Incheon-Korea, South Korea
| | - S K Yoon
- Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul-Korea, South Korea
| | - H J Yim
- Korea University Ansan Hospital, Ansan-si, Gyeonggi-do-Korea, South Korea
| | - W Y Tak
- Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, South Korea
| | - S Y Han
- Dong-A University Medical Center, Busan-Korea, South Korea
| | - J C Yang
- Gilead Sciences Inc., Foster City, CA, USA
| | - H Mo
- Gilead Sciences Inc., Foster City, CA, USA
| | - A Mathias
- Gilead Sciences Inc., Foster City, CA, USA
| | - L Han
- Gilead Sciences Inc., Foster City, CA, USA
| | - S J Knox
- Gilead Sciences Inc., Foster City, CA, USA
| | | | - Y J Kim
- Seoul National University Hospital, Seoul National University College of Medicine and Liver Research Institute, Seoul, Korea
| | - K S Byun
- Korea University Guro Hospital, Seoul-Korea, South Korea
| | - Y S Kim
- Soonchunhyang University Bucheon Hospital, Bucheon-Korea, South Korea
| | - J Heo
- Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Korea
| | - K H Han
- Yonsei University College of Medicine, Seoul-Korea, South Korea
| |
Collapse
|
42
|
Heo J, Noh O, Lee H, Chun M, Oh Y, Kim J. EP-1259: Clinical significance of lymphocyte count before chemoradiotherapy in resected pancreatic cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32509-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
43
|
Heo J, Chun M, Oh Y, Noh O, Kim J. EP-1462: Effects of education using Youtube about radiotherapy process for cancer patients. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32712-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
44
|
Kim W, Lee S, Lee E, Namkoong K, Choe K, Song J, Cheong H, Jeong H, Heo J. Incidence of narcolepsy before and after the pandemic influenza a (H1N1) vaccination in the Korean military. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.1543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Zeuzem S, Flisiak R, Vierling JM, Mazur W, Mazzella G, Thongsawat S, Abdurakhmanov D, Van Kính N, Calistru P, Heo J, Stanciu C, Gould M, Makara M, Hsu SJ, Buggisch P, Samuel D, Mutimer D, Nault B, Merz M, Bao W, Griffel LH, Brass C, Naoumov NV. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Aliment Pharmacol Ther 2015; 42:829-44. [PMID: 26238707 DOI: 10.1111/apt.13342] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2015] [Revised: 03/29/2015] [Accepted: 07/08/2015] [Indexed: 12/11/2022]
Abstract
BACKGROUND Alisporivir (ALV) is an oral, host-targeting agent with pangenotypic anti-hepatitis C virus (HCV) activity and a high barrier to resistance. AIM To evaluate efficacy and safety of ALV plus peginterferon-α2a and ribavirin (PR) in treatment-naïve patients with chronic HCV genotype 1 infection. METHODS Double-blind, randomised, placebo-controlled, Phase 3 study evaluating ALV 600 mg once daily [response-guided therapy (RGT) for 24 or 48 weeks or 48 weeks fixed duration] or ALV 400 mg twice daily RGT with PR, compared to PR alone. Following a Food and Drug Administration partial clinical hold, ALV/placebo was discontinued and patients completed treatment with PR only. At that time, 87% of patients had received ≥12 weeks and 20% had received ≥24 weeks of ALV/PR triple therapy. RESULTS A total of 1081 patients were randomised (12% cirrhosis, 55% CT/TT IL28B). Addition of ALV to PR improved virological response in a dose-dependent fashion. Overall, sustained virological response (SVR12; primary endpoint) was 69% in all ALV groups vs. 53% in PR control. Highest SVR12 (90%) was achieved in patients treated with ALV 400 mg twice daily and PR for >24 weeks. Seven cases of pancreatitis were reported, with similar frequency between ALV/PR and PR control groups (0.6% vs. 0.8% respectively). Adverse events seen more frequently with ALV/PR than with PR alone were anaemia, thrombocytopenia, hyperbilirubinaemia and hypertension. CONCLUSIONS Alisporivir, especially the 400 mg twice daily regimen, increased efficacy of PR therapy in treatment-naïve patients with HCV genotype 1 infection. The mechanism of action and pangenotypic activity suggest that alisporivir could be useful in interferon-free combination regimens.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - B Nault
- Novartis Pharma AG, Basel, Switzerland
| | - M Merz
- Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - W Bao
- Novartis Pharmaceuticals, East Hanover, NJ, USA
| | - L H Griffel
- Novartis Pharmaceuticals, East Hanover, NJ, USA
| | - C Brass
- Novartis Pharmaceuticals, East Hanover, NJ, USA
| | | | | |
Collapse
|
46
|
Cho B, Kim J, Kim B, Tak T, Heo J. Cytotoxic effect of Methylisothiazolinone humidifier disinfectants in Raw 264.7 Cells. Toxicol Lett 2015. [DOI: 10.1016/j.toxlet.2015.08.655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
47
|
Heo J, Kim H, Chun M, Oh Y, Noh O, Cho O. EP-1275: Treatment compliance in elderly patient with advanced cervical cancer during concurrent chemoradiothrapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41267-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
48
|
Lim K, Jing K, Shin S, Jeong S, Kim S, Heo J, Kweon G, Park S, Park J. 772: Docosahexaenoic acid may indirectly increase proteasome activity through reactive oxygen species in human cervical cancer HeLa cells. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)50677-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther 2014; 39:609-18. [PMID: 24461252 DOI: 10.1111/apt.12633] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/09/2013] [Revised: 12/19/2013] [Accepted: 01/04/2014] [Indexed: 12/11/2022]
Abstract
BACKGROUND Whether the incidence of metachronous gastric dysplasia and cancer could be decreased by eradication of Helicobacter pylori after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). AIM To compare the incidence of metachronous gastric lesion in the eradicated group and the persistent group. Second end point is to evaluate the risk factors for metachronous gastric lesions after ESD for EGC. METHODS In a single centre, between May 2007 and May 2010, the patients who had evidence of H. pylori infection at the time of ESD for EGC were included, and the follow-up data were analysed retrospectively. RESULTS We enrolled 283 patients who have shown H. pylori infection at the time of ESD for EGC. Successful eradication was achieved for 214 patients (75.6%) (Eradicated group), and 69 patients (24.4%) showed persistent H. pylori infection (Persistent group). Metachronous gastric lesions developed in 13 (18.8%) in the persistent group and 18 (8.4%) in the eradicated group (P = 0.016). In the ≥60-year-old group, the cumulative incidence of metachronous gastric cancer showed a significant increase (P = 0.012). Cumulative hazard ratio of subsequent gastric metachronous lesions differed between the eradication group and the persistent infection group (OR = 2.322, 95% CI = 1.136-4.744, P = 0.021), and ≥60 age at the time of endoscopic resection (OR = 2.803, 95% CI = 1.207-6.509, P = 0.016). CONCLUSIONS Both persistent H. pylori infection and old age (≥60) are independent risk factors for the increased incidence of metachronous gastric cancer.
Collapse
Affiliation(s)
- Y H Kwon
- Division of Gastroenterology, Department of Internal Medicine, Kyungpook National University Medical Center, Daegu, South Korea
| | | | | | | | | |
Collapse
|
50
|
Heo J, Noh O, Chun M, Oh Y, Kim M, Park H. EP-1255: Predictive factors for pathologic complete response after preoperative chemoradiotherapy in rectal cancer. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31373-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|